From the Department of Neurology (J.-M.K.), Seoul National University Hospital; Departments of Neurology (K.-Y.P., S.-H.H., H.-B.J., J.B.), Laboratory Medicine (H.R.K.), and Internal Medicine (H.Y.A.), Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea; Luigi Sacco Stroke and Dementia Lab (L.P.), Department of Biomedical and Clinical Sciences, University of Milan, Italy; and Department of Neurology (M.-S.P.), Seoul Hospital Ewha Womans University College of Medicine, South Korea.
Neurology. 2021 Mar 2;96(9):e1290-e1300. doi: 10.1212/WNL.0000000000011526. Epub 2021 Jan 11.
To test the hypothesis that bone mineral loss is mechanistically related to cerebral small vessel disease (SVD), we investigated the relationship between bone mineral density and the prevalence and intensity of SVD among patients with stroke.
We analyzed data of 1,190 consecutive patients with stroke who were >50 years of age and underwent both brain MRI and dual-energy x-ray absorptiometry from the stroke registry of Chung-Ang University Hospital in Seoul, Korea. The patients were categorized into 3 groups according to their bone mineral density (normal, osteopenia, and osteoporosis). White matter hyperintensities, silent lacunes, cerebral microbleeds, and extensive perivascular space were assessed from brain MRI. Multinomial logistic regression model was used to examine the association between osteoporosis and total SVD score. We also recruited 70 patients with stroke to study serum bone turnover markers and microRNAs related to both cerebral atherosclerosis and bone metabolism to understand bone and brain interaction.
Osteoporosis was determined among 284 patients (23.9%), and 450 patients (37.8%) had osteopenia. As bone mineral density decreased, total SVD score and the incidence of every SVD phenotype increased except strictly lobar cerebral microbleeds. Multinomial logistic regression analysis showed that osteoporosis was independently associated with severe SVD burden. The levels of microRNA-378f were significantly increased among the patients with osteoporosis and maximal total SVD score and positively correlated with parathyroid hormone and osteocalcin.
These findings suggest a pathophysiologic link between bone mineral loss and hypertensive cerebral arteriolar degeneration, possibly mediated by circulating microRNA.
为了验证骨矿物质丢失与脑小血管病(SVD)在机制上相关的假说,我们研究了骨密度与卒中患者 SVD 的患病率和严重程度之间的关系。
我们分析了来自韩国首尔钟央大学医院卒中登记处的 1190 例年龄大于 50 岁的连续卒中患者的数据,这些患者均接受了脑部 MRI 和双能 X 射线吸收法检查。根据骨密度(正常、骨量减少和骨质疏松症),患者被分为 3 组。从脑部 MRI 评估白质高信号、无症状腔隙、脑微出血和广泛的血管周围间隙。采用多项逻辑回归模型来检查骨质疏松症与总 SVD 评分之间的关联。我们还招募了 70 例卒中患者,研究与脑动脉粥样硬化和骨代谢相关的血清骨转换标志物和 microRNAs,以了解骨骼和大脑的相互作用。
确定了 284 例(23.9%)患者存在骨质疏松症,450 例(37.8%)患者存在骨量减少。随着骨密度降低,总 SVD 评分和每种 SVD 表型的发生率均增加,除了严格的脑叶微出血。多项逻辑回归分析显示,骨质疏松症与严重的 SVD 负担独立相关。在骨质疏松症和最大总 SVD 评分患者中,microRNA-378f 的水平显著升高,与甲状旁腺激素和骨钙素呈正相关。
这些发现提示骨矿物质丢失与高血压性脑小动脉退行性变之间存在病理生理联系,可能通过循环 microRNA 介导。